Unaudited Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2021	$ 366,327	$ 41	$ 413,967	$ (270)	$ (47,411)
Beginning balance (in shares) at Dec. 31, 2021		41,243,137
Exercise of common stock options	1		1
Exercise of common stock options (in shares)		7,405
Shares issued under employee stock purchase plan	307		307
Shares issued under employee stock purchase plan (in shares)		32,662
Vesting of restricted shares	881	$ 1	880
Vesting of restricted shares (in shares)		267,500
Stock-based compensation	12,998		12,998
Unrealized gain (loss) on available-for-sale securities, net	(2,007)			(2,007)
Net loss	(46,994)				(46,994)
Ending balance at Sep. 30, 2022	331,513	$ 42	428,153	(2,277)	(94,405)
Ending balance (in shares) at Sep. 30, 2022		41,550,704
Beginning balance at Jun. 30, 2022	343,814	$ 42	423,388	(1,907)	(77,709)
Beginning balance (in shares) at Jun. 30, 2022		41,501,269
Vesting of restricted shares	169		169
Vesting of restricted shares (in shares)		49,435
Stock-based compensation	4,596		4,596
Unrealized gain (loss) on available-for-sale securities, net	(370)			(370)
Net loss	(16,696)				(16,696)
Ending balance at Sep. 30, 2022	331,513	$ 42	428,153	(2,277)	(94,405)
Ending balance (in shares) at Sep. 30, 2022		41,550,704
Beginning balance at Dec. 31, 2022	320,740	$ 42	432,703	(1,535)	(110,470)
Beginning balance (in shares) at Dec. 31, 2022		41,616,260
Issuance of common stock and pre-funded common stock warrants, net of issuance costs	56,530	$ 4	56,526
Issuance of common stock and pre-funded common stock warrants, net of issuance costs (in shares)		4,153,717
Exercise of pre-funded common stock warrants (in shares)		80,257
Exercise of common stock options	$ 1,659		1,659
Exercise of common stock options (in shares)	191,879	191,879
Shares issued under employee stock purchase plan	$ 528		528
Shares issued under employee stock purchase plan (in shares)		57,911
Vesting of restricted shares	144		144
Vesting of restricted shares (in shares)		51,403
Stock-based compensation	15,522		15,522
Unrealized gain (loss) on available-for-sale securities, net	360			360
Net loss	(46,535)				(46,535)
Ending balance at Sep. 30, 2023	348,948	$ 46	507,082	(1,175)	(157,005)
Ending balance (in shares) at Sep. 30, 2023		46,151,427
Beginning balance at Jun. 30, 2023	299,469	$ 42	445,924	(1,060)	(145,437)
Beginning balance (in shares) at Jun. 30, 2023		41,867,536
Issuance of common stock and pre-funded common stock warrants, net of issuance costs	56,530	$ 4	56,526
Issuance of common stock and pre-funded common stock warrants, net of issuance costs (in shares)		4,153,717
Exercise of pre-funded common stock warrants (in shares)		80,257
Exercise of common stock options	79		79
Exercise of common stock options (in shares)		43,230
Vesting of restricted shares	5		5
Vesting of restricted shares (in shares)		6,687
Stock-based compensation	4,548		4,548
Unrealized gain (loss) on available-for-sale securities, net	(115)			(115)
Net loss	(11,568)				(11,568)
Ending balance at Sep. 30, 2023	$ 348,948	$ 46	$ 507,082	$ (1,175)	$ (157,005)
Ending balance (in shares) at Sep. 30, 2023		46,151,427